Thursday, Apr 25 2024 | Time 14:42 Hrs(IST)
image
Business Economy


Frost & Sullivan Recognizes Xenex with 2020 Global Company of the Year Award; LightStrike Robots Dominate Healthcare Room Disinfection Devices Market

The Xenex solution's efficiency in deactivating even the most challenging pathogens and its strong customer-centricity make it a highly relevant tool during a pandemic
LONDON, Sept. 23, 2020 /PRNewswire/ -- Based on its recent analysis of the global healthcare room disinfection devices market, Frost & Sullivan recognizes Xenex with the 2020 Global Company of the Year Award for being at the vanguard of the fight against SARS-CoV-2, the virus that causes COVID-19, with its proprietary LightStrike Germ-Zapping Robots. Powered by a patented technology that sends intense UV light across the entire germicidal spectrum (200 to 315 nanometers), the LightStrike destroys even the most challenging pathogen in a 5-minute cycle. Using this tool, customers can disinfect dozens of rooms every day as a part of their infection control protocols, and LightStrike supports customers' efforts to remove pathogens that can cause infections if not effectively disinfected.
Xenex's pulsed xenon UV light sets new standards in hospital environmental disinfection, which is a critical and necessary step to reduce the presence of pathogens that can cause hospital-acquired infections (HAIs). It is the only UV disinfection company that has more than a dozen hospitals publishing peer-reviewed studies on the solution's efficacy. Significantly, due to the impact of COVID-19, LightStrike is being adopted by customers even outside of the healthcare sector, including hotels, airports and other government buildings, schools, professional sports facilities, police stations, pharmaceutical clean rooms, and food processing facilities.
"Xenex's UV light operates much faster than other UV technologies. For instance, the LightStrike robot runs an average of 5 minutes to deactivate C.diff spores while mercury bulb devices may require extended run times of up to 52 minutes," said Dr. Bejoy Daniel, Senior Industry Analyst at Frost & Sullivan. "Furthermore, as LightStrike robots do not require warm-up and cool-down time, they can disinfect an entire patient room in the same amount time it takes for an autonomous robot to begin its disinfection process. The robots do not damage surface materials and have safely run more than 24 million cycles."
For new clients, Xenex sends a team onsite to train hospital staff on how the robots work, when to use them, and how to monitor and analyze utilization data. The UV light robots collect multiple parameters (such as room type, location, run time, as well as the operator who ran it) and upload the data to a cloud-based portal. The solution allows the hospital to track use, analyze the system's efficacy, and identify gaps in workflows.
"Xenex focuses not just on selling products, but on solving issues for hospitals. This customer focus, along with its unique value proposition, enables the company to own 55% of the global healthcare UV disinfection solutions market," noted Dr. Daniel. "It is the first and only UV room disinfection technology proven to deactivate SARS-CoV-2, the virus that causes COVID-19. The LightStrike robot achieves a >99.99% disinfection against SARS-CoV-2 on surfaces in 2 minutes, making it a vital tool in the current environment and cementing its leadership position in the market."
Each year, Frost & Sullivan presents a Company of the Year award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.
About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
Contact:
Lindsey Whitaker
P: +1 (210) 477-8457
E: [email protected]
About Xenex
Xenex is a world leader in UV technology-based disinfection strategies and solutions. Xenex's mission is to save lives and reduce suffering by destroying the deadly microorganisms that can cause infections. Xenex is backed by well-known investors that include EW Healthcare Partners, Piper Jaffray, Malin Corporation, Battery Ventures, Targeted Technology Fund II, Tectonic Ventures and RK Ventures. For more information, visit xenex.com.
(Disclaimer--Features may vary depending on the regions; subject to change without notice.)
More News
SBI General Insurance records 17 pc growth in topline and a profit growth of 30 pc in FY 23-24

SBI General Insurance records 17 pc growth in topline and a profit growth of 30 pc in FY 23-24

25 Apr 2024 | 2:18 PM

Kolkata, Apr 25 (UNI) SBI General Insurance announced its financial results for FY 23-24, recording 17 per cent growth in topline faster than market growth and a profit growth of 30 per cent in FY 23-24.

see more..
Tata Motors accelerates innovation: record 222 patents filed and 333 grants secured in FY24

Tata Motors accelerates innovation: record 222 patents filed and 333 grants secured in FY24

25 Apr 2024 | 1:10 PM

Hyderabad, Apr 25 (UNI) Part of the USD 150 billion Tata group, Tata Motors Limited, India’s leading automobile company, has yet again achieved a significant milestone towards intellectual property rights (IPR) creation with a record-breaking number of 222 Patents and 117 designs applications filed during the year FY24, highest in its history.

see more..

RITES collaborates with DVC for rail infra works

25 Apr 2024 | 1:05 PM

Mumbai, April 25 (UNI) RITES Ltd., a prime transport infrastructure consultancy on Thursday said that it has signed an MoU with Damodar Valley Corporation (DVC), a statutory body under the Ministry of Power, to collaborate for Project Management Consultancy for rail infra works.

see more..

JioCinema to redefine subscription market with launch of Premium Plans

25 Apr 2024 | 12:42 PM

Mumbai, April 25 (UNI) JioCinema, the video streaming platform of Reliance Industries, has rolled out new subscription plans, JioCinema Premium, which will include ad-free content across languages, including original series, movies, children's shows, and TV entertainment on any device, including connected TV sets, for Rs 29 a month.

see more..
Rupee falls 6 paise against USD

Rupee falls 6 paise against USD

25 Apr 2024 | 12:15 PM

Mumbai, April 25 (UNI) The Rupee on Thursday declined 6 paise at 83.38 against USD in opening session on rising demand for US Dollar by bankers and importers, dealers at the Foreign Exchange said.

see more..
image